Q3 FY23 Earnings Presentation

Table of Executive Portfolio Financial Guidance & Contents Summary Highlights Highlights Assumptions ESG Appendix Q3 FY23 Regional organic revenue growth 4.1% WW organic growth driven by 16.9% EM growth ex. China and MSD growth in non-U.S. developed markets United States Western Europe Japan Non-U.S. Developed 6.0% Australia & New Zealand Canada South Korea 2.5% ▲ High-single digits Low-single digits ▲ Low-double digits ▲ High-single digits Mid-teens Emerging Markets 5.4% China Middle East & Africa Latin America Eastern Europe Southeast Asia South Asia High-single digits Low-double digits ▲ High-teens Low-20's Mid-teens Low-20's 7 | Q3 FY23 Earnings Presentation | February 21, 2023 Medtronic

View entire presentation